Nestle's Vitamins Business Sale Should Lead to Minimal Earnings Dilution

Dow Jones
Yesterday

0619 GMT - Nestle's $1 billion deal to sell its mainstream vitamins, minerals and supplements business to private-equity group Yellow Wood Partners should result in a minimal dilution of the Swiss food giant's earnings, J.P. Morgan analysts say in a research note. The business generated roughly 1.1% of Nestle's sales last year and was a lower-margin part of the group's portfolio, according to JPM. Nestle will keep premium vitamins, minerals and supplements brands like Solgar and Pure Encapsulations. "The combination of the mainstream and premium [vitamins, minerals and supplements] businesses brought scale and breadth of brands that had manufacturing and [route-to-market] synergies that have since become less relevant, and Nestle has emphasized the strong performance of the premium [vitamins, minerals and supplements] business," the analysts say.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10